Skip to main content
Larry Junck, MD, Oncology, Ann Arbor, MI

Larry Richard Junck MD

Neuro-Oncology


Professor of Neurology, Univ of Michigan Medical School

Join to View Full Profile
  • 1500 E Medical Center DrAnn Arbor, MI 48109

  • Phone+1 734-936-4000

Dr. Junck is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1981 - 1983
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Neurology, 1977 - 1980
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 1976 - 1977
  • University of Michigan Medical School
    University of Michigan Medical SchoolClass of 1976

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1977 - Present
  • NY State Medical License
    NY State Medical License 1980 - Present
  • MI State Medical License
    MI State Medical License 1983 - 2026
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Publications & Presentations

PubMed

Grant Support

  • ZD1839 For Recurrent/ Progressive Malig Astrocytoma, Glioblastoma, &MeningiomaNational Center For Research Resources2004
  • Phase I/II Trial Of CCI-779 (Nsc# 683864) In Patients W/ Malignant GliomaNational Center For Research Resources2004
  • Phase I/II Trial Cpt-11&Temozolomide(Temodar)In Pts.W/Malignant Glioma Umcc 0048National Center For Research Resources2004
  • Phase II Study Of Su101 For Patients With Anaplastic ASTNational Center For Research Resources2000–2002
  • Su101 Versus Procarbazine For First Relapse Patients W/ GlioblastomaNational Center For Research Resources1999–2002
  • Regional Brain Activation In Patients With Brain TumorsNational Center For Research Resources1996–2002
  • PET Growth Kinetics And Neuropathology Of Brain TumorsNational Cancer Institute1991–1994
  • PETT Studies Of Brain MetabolismNational Institute Of Neurological Disorders And Stroke1988
  • PET Studies Of Brain MetabolismNational Institute Of Neurological Disorders And Stroke1985–1987

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: